QUANTIFICATION OF THE O-DEMETHYLATED AND N-DEMETHYLATED AND THE GLUCURONIDATED METABOLITES OF CODEINE RELATIVE TO THE DEBRISOQUINE METABOLIC RATIO IN URINE IN ULTRARAPID, RAPID, AND POOR DEBRISOQUINE HYDROXYLATORS
Qy. Yue et al., QUANTIFICATION OF THE O-DEMETHYLATED AND N-DEMETHYLATED AND THE GLUCURONIDATED METABOLITES OF CODEINE RELATIVE TO THE DEBRISOQUINE METABOLIC RATIO IN URINE IN ULTRARAPID, RAPID, AND POOR DEBRISOQUINE HYDROXYLATORS, Therapeutic drug monitoring, 19(5), 1997, pp. 539-542
The O-demethylation of codeine is polymorphic and catalyzed by CYP2D6.
The metabolites of codeine formed through O- and N-demethylation as w
ell as glucuronidation were quantified in the ultrarapid metabolizers
of debrisoquine and compared with the normal extensive (EM) and poor m
etabolizers (PM). The urinary codeine and its seven metabolites were d
etected after 25 mg codeine in 24 healthy Caucasian subjects with low
debrisoquine metabolic ratios (MR, less than or equal to 0.11) and a g
roup of 132 subjects tested earlier with codeine and debrisoquine incl
uding 114 EMs (MR < 12.6) and 18 PMs (MR > 12.6). Whereas the O-demeth
ylated metabolites accounted for <0.4% of the total recovery on averag
e in the PMs and 1.7% to 8.7% in the EMs, they accounted for 15.3% in
the 24 subjects with ultrarapid metabolism of debrisoquine. This study
suggests that the ultrarapid debrisoquine hydroxylators may develop i
ncreased O-demethylated metabolite-dependent effects or side-effects o
f codeine.